Profit jumps despite declined revenue at Ganga Pharmaceuticals in HY1 FY19-20
Ganga Pharmaceuticals registered revenue of Rs.1.45 crore in HY1 of FY19-20 against previous years Rs.1.83 crore
Company : GCM Commodity & Derivatives Ltd
In HY1 of FY19-20, Ganga Pharmaceuticals Limited achieved Rs.15.53 Lacs profit after tax whereas in the corresponding period last year, it was Rs.14.88 lacs.
Earnings per share for the current half year was Rs.0.04 as against Rs.0.37 in previous year same period.
Ganga Pharmaceuticalsreported Rs.18.71 lacs annual profit in FY2018-19 and earned revenue of Rs.3.50 crore.
\n | Current Year Upto | \nPrevious Year Upto | \nPrevious Year | \n
---|---|---|---|
\n | 30/9/2019 | \n30/9/2018 | \n2018-2019 | \n
Income Statement | \n|||
Revenue | \n138.24 | \n176.52 | \n336.26 | \n
Other Income | \n7.50 | \n6.92 | \n14.39 | \n
Total Income | \n145.74 | \n183.44 | \n350.65 | \n
Expenditure | \n109.97 | \n147.35 | \n294.38 | \n
Finance Cost | \n12.18 | \n12.29 | \n25.13 | \n
PBDT | \n23.59 | \n23.8 | \n31.14 | \n
Depreciation | \n2.60 | \n3.76 | \n5.29 | \n
PBT | \n20.99 | \n20.04 | \n25.85 | \n
Tax | \n5.45 | \n5.16 | \n7.13 | \n
Net Profit | \n15.54 | \n14.88 | \n18.72 | \n
Equity | \n406.15 | \n406.15 | \n406.15 | \n
EPS | \n0.04 | \n0.37 | \n0.46 | \n
Recent Stories
- WINNERS